Skip to main content
SpringerLink
Log in

Carcinoma and the peripheral nervous system

  • ENS Review
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

An underlying carcinoma is an important differential diagnosis in peripheral neuropathy. While direct compression and infiltration of spinal roots or peripheral or cranial nerve trunks or branches can be identified easily when they occur in association with established malignancy, their diagnosis when they are presenting features may be difficult. In paraneoplastic sensory neuronopathy autoantibodies to neuronal antigens have become useful diagnostic markers for an underlying carcinoma, especially anti-Hu antibodies. Strong circumstantial evidence suggests that these antibodies form part of an autoimmune response which is responsible for the pathogenesis of some of these syndromes. Neuropathy appearing during the course of treatment of carcinoma may be due to radiation-induced damage or the neurotoxic effects of some chemotherapeutic agents. Neurotrophic factors are being investigated as a strategy for reducing the neurotoxic effects of these agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Burt RK, Sharfman WH, Karp BI, Wilson WH (1992) Mental neuropathy (numb chin syndrome). A harbinger of tumor progression or relapse. Cancer 70:877–881

    PubMed  Google Scholar 

  2. Croft PB, Wilkinson M (1965) The incidence of carcinomatous neuromyopathy in patients with various types of carcinoma. Brain 88:427–434

    PubMed  Google Scholar 

  3. Croft PB, Wilkinson M (1969) The incidence of carcinomatous neuromyopathy in patients with various types of carcinoma. Brain 92:1–24

    PubMed  Google Scholar 

  4. Dalmau J, Posner JB (1994) Neurologic paraneoplastic antibodies (antiYo; anti-Hu; anti-Ri): the case for a nomenclature based on antibody and antigen specificity. Neurology 44:2241–2246

    PubMed  Google Scholar 

  5. Dalmau J, Fumeaux HM, Rosenblum MK, Graus F, Posner JB (1991) Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Neurology 41:1757–1764

    PubMed  Google Scholar 

  6. Dalmau J, Graus F, Rosenblum MK, Posner JB (1992) Anti-Hu associated paraneoplastic encephalomyelitis sensory neuropathy: a clinical study of 71 patients. Medicine 71:59–72

    PubMed  Google Scholar 

  7. Darnell RB, DeAngelis LM (1993) Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet 341:21–22

    PubMed  Google Scholar 

  8. Denny-Brown D (1948) Primary sensory neuropathy with muscular changes associated with carcinoma. J Neurol Neurosurg Psychiatry 11:73–87

    Google Scholar 

  9. Gerritsen RG vd, Vecht CJ, Van der Burg MEL, Elderson A, Boogerd W, Heimans JJ, Vries EP, Houwelingen JC van, Jennekens FGI, Gispen WH, Neijt JP (1990) Prevention of cisplatin neurotoxicity with an ACTH(4–9) analogue in patients with ovarian cancer. N Engl J Med 322:89–94

    PubMed  Google Scholar 

  10. Graus F, Cordon-Cardo C, Posner JB (1985) Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology 35:538–543

    PubMed  Google Scholar 

  11. Graus F, Ribalta T, Campo E, Monforte R, Urbano A, Rozman C (1990) Immunohistochemical analysis of the immune reaction in the nervous system in paraneoplastic encephalomyelitis. Neurology 40:219–222

    PubMed  Google Scholar 

  12. Gupta SR, Zdonczyk DE, Rubino FA (1990) Cranial neuropathy in systemic malignancy in a VA population. Neurology 40:997–999

    PubMed  Google Scholar 

  13. Hoh CK, Hawkins RA, Glaspy JA, Dahlbom M, Tse NY, Hoffman EJS, Choi Y, Rege S, Nitzsche E, et al (1993) Cancer detection with wholebody PET using 2-[18F]fluoro-2-deoxy-d-glucose. J Comput Assist Tomogr 17:582–589

    PubMed  Google Scholar 

  14. Hughes RAC, Britton T, Richards M (1994) Effects of lymphoma on the peripheral nervous system. J R Soc Med 87:526–530

    PubMed  Google Scholar 

  15. Jaeckle KA (1991) Nerve plexus metastases (review). Neurol Clin 9:857–866

    PubMed  Google Scholar 

  16. Jean WC, Dalmau J, Ho A, Posner JB (1994) Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu-associted paraneoplastic encephalomyelitis. Neurology 44:140–147

    PubMed  Google Scholar 

  17. Jett JR (1993) Current treatment of unresectable lung cancer. Mayo Clin Proc 68:603–611

    PubMed  Google Scholar 

  18. Kori SH, Foley KM, Posner JB (1981) Brachial plexus lesions in patients with cancer: 100 cases. Neurology 31:45–50

    PubMed  Google Scholar 

  19. Leung SF, Tsao SY, Teo P, Foo W (1990) Cranial nerve involvement by nasopharyngeal carcinoma: response to treatment and clinical significance. Clin Oncol 2:138–141

    Google Scholar 

  20. Lin KP, Kwan SY, Chen SY, Chen SS, Yeung KB, Chia LG, Wu ZA (1993) Generalized neuropathy in Taiwan: an etiologic survey. Neuroepidemiology 12:257–261

    PubMed  Google Scholar 

  21. Lipton RB, Galer BS, Dutcher JP, Portenoy RK, Berger A, Arezzo JCM, Wiemik PH, Schaumburg HH (1987) Quantitative sensory testing demonstrates that subclinical sensory neuropathy is prevalent in patients with cancer. Arch Neurol 44:944–946

    PubMed  Google Scholar 

  22. Lossos A, Siegal T (1992) Numb chin syndrome in cancer patients: etiology, response to treatment, and prognostic significance (see comments). Neurology 42:1181–1184

    PubMed  Google Scholar 

  23. McLeod JG (1993) Paraneoplastic neuropathies. In: Dyck PJ, Thomas PK (eds) Peripheral neuropathy. Saunders, Philadelphia, pp 1583–1590

    Google Scholar 

  24. Mollman JE (1990) Cisplatin neurotoxicity. N Engl J Med 322:126–127

    PubMed  Google Scholar 

  25. Moody JF (1965) Electrophysiological investigations into the neurological complications of carcinoma. Brain 88:1023–1036

    PubMed  Google Scholar 

  26. Pandha H, Waxman J, Sikora K (1995) Tumor markers. Br J Hosp Med 51:297–303

    Google Scholar 

  27. Rogers LR, Borkowski GP, Albers JW, Levin KH, Barohn RJ, Mitsumoto H (1993) Obturator mononcuropathy caused by pelvic cancer: six cases. Neurology 43:1489–1492

    PubMed  Google Scholar 

  28. Rowinsky EK, Donehower RC (1995) Paclitaxel (taxol). N Engl J Med 332:1004–1014

    PubMed  Google Scholar 

  29. Sham JS, Cheung YK, Choy D, Chan FL, Leong L (1991) Cranial nerve involvement and base of the skull erosion in nasopharyngeal carcinoma. Cancer 68:422–426

    PubMed  Google Scholar 

  30. Van der Hoop RG, Vecht CJ, Van der Burg MEL, Elderson A, Boogerd W, Heimans JJ, Vries EP, Houwelingen JC van, Jennekens FGI, Gispen WH, Neijt JP (1990) Prevention of cisplatin neurotoxicity with an ACTH (4-9) analogue in patients with ovarian cancer. N Engl J Med 322:89–94

    PubMed  Google Scholar 

  31. Wilbourn AJ (1993) Brachial plexus disorders. In: Dyck PJ, Thomas PK (eds) Peripheral neuropathy. Saunders, Philadelphia, pp 911–950

    Google Scholar 

  32. Wong K, Henderson IC (1994) Management of metastatic breast cancer (review). World J Surg 18:98–111

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, UMDS, Guy's Hospital, SEI 9RT, London, UK

    Richard Hughes & Basil Sharrack

  2. Division of Clinical Oncology, UMDS, Guy's Hospital, SEI 9RT, London, UK

    Robert Rubens

Authors
  1. Richard Hughes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Basil Sharrack
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert Rubens
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hughes, R., Sharrack, B. & Rubens, R. Carcinoma and the peripheral nervous system. J Neurol 243, 371–376 (1996). https://doi.org/10.1007/BF00868994

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00868994

Key words

Search

Navigation